Thu, Jun. 23, 8:40 AM
- Nano cap Oragenics (NYSEMKT:OGEN) agrees to sell its Consumer Probiotic Business to ProBiora Health, LLC, an entity controlled by board member Christine Koski, for $1.7M in cash plus up to an additional $300K based on a percentage of sales over a 10-year period. The deal should close by tomorrow.
- Shares are up 40% premarket on light volume.
Oragenics, Inc. is a biopharmaceutical company, which is focused on oral probiotics products and novel antibiotics for humans and companion pets. It also develops, markets and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names.... More
Country: United States